28 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:24am
to strengthen group-wide compliance systems. The Company has established its Code of Conduct, global policies (prohibition of bribery, handling of personal
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
Code of Conduct, global policies (prohibition of bribery, handling of personal information, prohibition of insider trading, etc.) and other compliance
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
of bribery, handling of personal information, prohibition of insider trading, etc.) and other compliance-related internal rules, and implements training
6-K
EX-99.1
gr7duf
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
ej77a4tsyssu7lz
30 May 23
Current report (foreign)
6:11am
6-K
EX-99.1
ue5d enksodpy06
17 Dec 20
Current report (foreign)
6:01am
F-3ASR
EX-1.1
v1sc83dbmpq4
24 Jun 20
Automatic shelf registration (foreign)
4:30pm
6-K
EX-99.1
tvr9eb 5jz
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
424B3
3f9c xipusgqz7rbc
14 Nov 19
Prospectus supplement
6:10am
F-4/A
f9wo9wt5
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
opg7oz
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
evo2 hp06
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
EX-10.7
qr817h xxmudt
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.9
56nsj6t
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.14
kunmg9am 4dikfjmf
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am